p.124 抽出テキスト

42) Rodríguez M, Barutell C, Rull M, et al. Efficacy and tolerance of oral dipyrone versus oral morphine for cancer pain. Eur J Cancer 1994;30A:584‒7 43) Bandieri E, Romero M, Ripamonti CI, et al. Randomized trial of low‒dose morphine versus weak opioids in moderate cancer pain. J Clin Oncol 2016;34:436‒42 44) Kress HG, Koch ED, Kosturski H, et al. Tapentadol prolonged release for managing moderate to severe, chronic malignant tumor‒related pain. Pain Physician 2014;17:329‒43 45) Leppert W. Analgesic efficacy and side effects of oral tramadol and morphine administered orally in the treatment of cancer pain. Nowotwory 2001;51:257‒66 46) Wilder‒Smith CH, Schimke J, Osterwalder B, et al. Oral tramadol, a mu‒opioid agonist and monoamine reuptake‒blocker, and morphine for strong cancer‒related pain. Ann Oncol 1994; 5:141‒6 47) 平賀一陽,大熊誠太郎,浅野弘明,他.【トラマドール塩酸塩(トラマール)の臨床的研究】癌性疼痛を対象とした弱オピオイド鎮痛薬NS‒315(トラマドール塩酸塩)の第III相臨床試験―モルヒネを対照としたランダム化二重盲検並行群間比較試験.臨医薬2010a;26:569‒84 48) 平賀一陽,大熊誠太郎,浅野弘明,他.【トラマドール塩酸塩(トラマール)の臨床的研究】癌性疼痛を対象とした弱オピオイド鎮痛薬NS‒315(トラマドール塩酸塩)の第III相臨床試験―モルヒネを対照としたランダム化二重盲検クロスオーバー試験.臨医薬2010b;26:555‒68 49) Lee KH, Kang JH, Oh HS, et al. Intravenous oxycodone versus intravenous morphine in cancer pain:a randomized, open‒label, parallel‒group, active-control study. Pain Res Manag 2017; 2017:9741729 50) Nosek K, Leppert W, Nosek H, et al. A comparison of oral controlled‒release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients. Drug Des Devel Ther 2017;11:2409‒19 51) Zhang WZ, Yu WJ, Zhao XL, et al. Pharmacoeconomics evaluation of morphine, MS contin and oxycodone in the treatment of cancer pain. Asian Pac J Cancer Prev 2014;15:8797‒800 52) Bruera E, Belzile M, Pituskin E, et al. Randomized, double‒blind, cross‒over trial comparing safety and efficacy of oral controlled‒release oxycodone with controlled‒release morphine in patients with cancer pain. J Clin Oncol 1998;16:3222‒9 53) Corli O, Floriani I, Roberto A, et al.;CERP study of pain group. Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV ʼreal lifeʼ trial on the variability of response to opioids. Ann Oncol 2016;27:1107‒15 54) Heiskanen T, Kalso E. Controlled‒release oxycodone and morphine in cancer related pain. Pain 1997;73:37‒45 55) Kalso E, Vainio A. Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther 1990;47:639‒46 56) Lauretti GR, Oliveira GM, Pereira NL. Comparison of sustained‒release morphine with sustained‒release oxycodone in advanced cancer patients. Br J Cancer 2003;89:2027‒30 57) Mercadante S, Tirelli W, David F, et al. Morphine versus oxycodone in pancreatic cancer pain: a randomized controlled study. Clin J Pain 2010;26:794‒7 58) Mucci‒LoRusso P, Berman BS, Silberstein PT, et al. Controlled‒release oxycodone compared with controlled‒release morphine in the treatment of cancer pain:a randomized, double‒ blind, parallel‒group study. Eur J Pain 1998;2:239‒49 59) Riley J, Branford R, Droney J, et al. Morphine or oxycodone for cancer‒related pain? A randomized, open‒label, controlled trial. J Pain Symptom Manage 2015;49:161‒72 60) Zecca E, Brunelli C, Bracchi P, et al. Comparison of the tolerability profile of controlled‒release oral morphine and oxycodone for cancer pain treatment. An open‒label randomized controlled trial. J Pain Symptom Manage 2016;52:783‒94 61) 武田文和,舘野政也,小山靖夫,他.癌患者の疼痛治療におけるS‒8117(塩酸オキシコドン徐放錠)と硫酸モルヒネ徐放錠との比較試験―第III相臨床試験.臨医薬2005;21:295‒313 62) Beaver WT, Wallenstein SL, Rogers A, et al. Analgesic studies of codeine and oxycodone in patients with cancer. II. Comparisons of intramuscular oxycodone with intramuscular morphine and codeine. J Pharmacol Exp Ther 1978;207:101‒8 63) Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained‒release oral morphine in cancer pain:preference, efficacy, and quality of life. The TTS‒Fentanyl Comparative Trial Group. J Pain Symptom Manage 1997;13:254‒61 64) Mercadante S, Porzio G, Ferrera P, et al. Sustained‒release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain 2008;12:1040‒6 65) van Seventer R, Smit JM, Schipper RM, et al. Comparison of TTS‒fentanyl with sustained‒

release oral morphine in the treatment of patients not using opioids for mild‒to‒moderate III章推奨